A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.

Name: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.
Published: 2008
License: Public Domain

Hoffmann-La Roche · 2008

ClinicalTrials.gov · Datasets · License: Public Domain · 2008

Open Source ↗

chronic hepatitis-c

hepatitis c, chronic, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.

Related documents